Results 101 to 110 of about 7,307 (207)
Beneficial physiological effects of long-chain n-3 polyunsaturated fatty acids are widely accepted but the mechanism(s) by which these fatty acids act remains unclear.
Christophe Morisseau +6 more
doaj +1 more source
An electrochemical Hofmann rearrangement of amide involving amine or other amide nucleophiles has been developed. The use of NaI guarantees the feasibility and compatibility of the electrosynthesis protocol, which enables highly chemoselective synthesis of unsymmetrical N‐acylureas from two different amides, as well as the production of unsymmetrical ...
Xue‐Qing Mou +9 more
wiley +1 more source
Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors [PDF]
A series of N,N‘-disubstituted ureas having a conformationally restricted cis- or trans-1,4-cyclohexane α to the urea were prepared and tested as soluble epoxide hydrolase (sEH) inhibitors.
Bruce D. Hammock (65754) +4 more
core +1 more source
Soluble epoxide hydrolase inhibition modulates vascular remodeling
The soluble epoxide hydrolase enzyme (SEH) and vascular remodeling are associated with cardiovascular disease. Although inhibition of SEH prevents smooth muscle cell proliferation in vitro, the effects of SEH inhibition on vascular remodeling in vivo and mechanisms of these effects remain unclear.
A N, Simpkins +5 more
openaire +3 more sources
Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer’s disease
Background Soluble epoxide hydrolase (sEH) is a bifunctional enzyme with COOH-terminal hydrolase and NH2-terminal lipid phosphatase activities. It is expressed in various cell types in the brain and is involved in the pathogenesis of inflammatory and ...
Hsueh-Te Lee +3 more
doaj +1 more source
Asp333, Asp495, and His523 form the catalytic triad of rat soluble epoxide hydrolase [PDF]
On the basis of the sequence similarity between mammalian epoxide hydrolases and bacterial haloalkane dehalogenase reported earlier (Arand, M., Grant, D. F., Beetham, J. K., Friedberg, T., Oesch, F., and Hammock, B. D. (1994) FEBS Lett.
Oesch, F +2 more
core +1 more source
Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
Osteoarthritis (OA) is a degenerative joint disease that causes pain and bone deterioration driven by an increase in prostaglandins (PGs) and inflammatory cytokines.
Cindy B. McReynolds +13 more
doaj +1 more source
Selaginellin derivatives 1–3 isolated from Selaginella tamariscina were evaluated for their inhibition of soluble epoxide hydrolase (sEH) to demonstrate their potential for the treatment of cardiovascular disease.
Jang Hoon Kim +6 more
doaj +1 more source
Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
Ocular diseases cause visual impairment and blindness, imposing a devastating impact on quality of life and a substantial societal economic burden. Many such diseases lack universally effective pharmacotherapies.
Bomina Park +4 more
doaj +1 more source
Bifunctional catalysis in human epoxide hydrolase [PDF]
The X-ray crystal structure of human soluble epoxide hydrolase (sEH) has been determined at 2.6 Å resolution, revealing a domain-swapped quaternary structure identical to that observed for the murine enzyme [Argiriadi, M.A., Morisseau, C., Hammock, B.D.,
Gomez, German Ariel
core

